Brand, R. M., Moore, B. A., Zyhowski, A., Siegel, A., Uttam, S., Metter, E. J., . . . McGowan, I. (2021). Tofacitinib inhibits inflammatory cytokines from ulcerative colitis and healthy mucosal explants and is associated with pSTAT1/3 reduction in T-cells. Am J Physiol Gastrointest Liver Physiol.
Styl cytowania ChicagoBrand, Rhonda M., et al. "Tofacitinib Inhibits Inflammatory Cytokines From Ulcerative Colitis and Healthy Mucosal Explants and Is Associated With PSTAT1/3 Reduction in T-cells." Am J Physiol Gastrointest Liver Physiol 2021.
Styl cytowania MLABrand, Rhonda M., et al. "Tofacitinib Inhibits Inflammatory Cytokines From Ulcerative Colitis and Healthy Mucosal Explants and Is Associated With PSTAT1/3 Reduction in T-cells." Am J Physiol Gastrointest Liver Physiol 2021.